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ABSTRACT The interaction between Nystatin and small unilamellar vesicles of 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line, both in gel (T = 210C) and in liquid-crystalline (T = 450C) phases, was studied by steady-state and time-resolved
fluorescence measurements by taking advantage of the intrinsic tetraene fluorophore present in this antibiotic. It was shown
that Nystatin aggregates in aqueous solution with a critical concentration of 3 puM. The enhancement in the fluorescence
intensity of the antibiotic was applied to study the membrane binding of Nystatin, and it was shown that the antibiotic had
an almost fivefold higher partition coefficient for the vesicles in a gel (P = (1.4 ± 0.1) x 103) than in a liquid-crystalline phase
(P = (2.9 ± 0.1) x 102). Moreover, a time-resolved fluorescence study was used to examine Nystatin aggregation in the
membrane. The emission decay kinetics of Nystatin was described by three and two exponentials in the lipid membrane at
210C and 450C, respectively. Nystatin mean fluorescence lifetime is concentration-dependent in gel phase lipids, increasing
steeply from 11 to 33 ns at an antibiotic concentration of 5-6 ,uM, but the fluorescence decay parameters of Nystatin were
unvarying with the antibiotic concentration in fluid lipids. These results provide evidence for the formation of strongly
fluorescent antibiotic aggregates in gel-phase membrane, an interpretation that is at variance with a previous study. However,
no antibiotic self-association was detected in a liquid-crystalline lipid bilayer within the antibiotic concentration range studied
(0-14 ,uM).
INTRODUCTION
The polyene macrolide antibiotics are a group of com-
pounds that share a common antifungal activity (Kobayashi
and Medoff, 1977). Among their components, Amphoteri-
cin B (AmpB) and Nystatin have a special importance
because they have been used in the treatment of systemic
and superficial mycotic infections, respectively, in spite of
the severe secondary effects that they exert (Medoff et al.,
1983). These two antibiotics are closely related inasmuch as
they have very similar molecular structures (Fig. 1), their
major differences being their polyenic chains (whereas
AmpB has a heptaene, the Nystatin molecule contains a
tetraene plus a diene) and some configurations in the polyol
region.
The polyene antibiotics act at the cell membrane level,
where they increase the cell permeability to ions and small
molecules, thereby promoting a leakage of important cellu-
lar constituents and ultimately lysis and death of the cell
(Bolard, 1986). In several experiments (e.g., De Kruijff
et al., 1974), the presence of sterols in the membranes was
found to be an essential requisite for maximal polyene
antibiotic sensitivity. Moreover, the antibiotic selectivity
may be related to the type of sterol present in the plasmatic
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membrane; ergosterol-rich fungal membranes are much
more sensitive to the action of the antibiotic than cholester-
ol-rich membranes, whereas sterol-free bacterial cells are
quite resistant to these molecules (Kinsky et al., 1966).
However, despite a large array of information obtained by a
variety of techniques, there is still considerable controversy
concerning the role of sterols in this process (for a compre-
hensive review see Bolard, 1986).
The most widely accepted model for the mode of action
of these antibiotics assumes that they form aqueous pores in
lipid membranes (Holz and Finkelstein, 1970). In fact,
Ermishkin et al. (1976) succeeded in measuring single ionic
channels in black-film membranes made from brain phos-
pholipids. The formation of transmembrane pores consti-
tuted by antibiotic-sterol complexes, composed of alter-
nated antibiotic and sterol molecules, was first proposed by
De Kruijff and Demel (De Kruijff and Demel, 1974; Van
Hoogevest and De Kruijff, 1978). On the other hand,
Finkelstein and co-workers (Marty and Finkelstein, 1975;
Kleinberg and Finkelstein, 1984) suggested that these anti-
biotics self-associated into pores and that sterols had only an
ordering function in packing the polyene molecules to-
gether. HsuChen and Feingold (1973) had also previously
proposed an indirect role for sterols in the mode of action of
the antibiotics through their modulation of membrane orga-
nization, i.e., through their capacity to change the phospho-
lipid packing in the membranes. According to these authors,
the interaction between polyenes and membranes required
the lipid bilayer to be in an ordered state. More recently,
Bolard et al. (1991) suggested that the permeability path-
ways induced by AmpB or Nystatin in the membranes
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FIGURE 1 Molecular structures of Nystatin A1 and Amphotericin B.
might depend on the type of sterol present in it. The for-
mation of an antibiotic-sterol complex would still be a valid
model for ergosterol-containing membranes, whereas for
cholesterol-rich membranes the antibiotics had to be added
to the aqueous solution in the self-associated form to be
active. Later studies gave further support to this model
(Legrand et al., 1992; Lambing et al., 1993). However,
it was shown in a recent circular dichroism (CD) study
(Balakrishnan and Easwaran, 1993a) that AmpB was capa-
ble of undergoing a concentration-dependent aggregation
when incorporated into bilayer membrane systems without
sterols. Moreover, these authors showed that ergosterol pro-
moted drug aggregation, i.e., made it occur at a lower drug
concentration. A completely different hypothesis for the
mechanism of action of these compounds was put forward
by Hartsel et al. (1991). These authors proposed that AmpB
could be active at membranes without sterols through the
formation of ion-conducting membrane defects at the anti-
biotic-lipid interface.
This work was focused on Nystatin, a polyene antibiotic
that has been less frequently studied than AmpB. We have
taken advantage of the intrinsic fluorescence properties of
the tetraene chromophore present in this molecule to study
its interaction with phospholipid bilayer membranes. Previ-
ous studies carried out with trans-parinaric acid (t-PnA)
(Hudson and Cavalier, 1988), a fatty acid with the same
fluorescent group as Nystatin, have shown that the tetraene
is an excellent reporter of the properties of its microenvi-
ronment, namely of its close density. We expected that the
fluorescence of Nystatin would also display this same sen-
sitivity, which would eventually allow us to monitor differ-
ent antibiotic species in the bilayer. Before addressing the
role of sterols in the Nystatin mode of action, we have
chosen to carry out this study with a simple model mem-
brane system, namely sonicated vesicles prepared with 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) both in
gel and in liquid-crystalline phases. The fluorescence prop-
erties of Nystatin were used here to characterize the parti-
tioning of this antibiotic to the membrane and to examine its
state of aggregation. Our results confirmed that the presence
of sterols in the lipid bilayer is not essential for antibiotic
binding to the vesicles and showed that Nystatin associates
preferentially with gel-like over fluid-like lipids. Moreover,
the changes in the emission decay kinetics of Nystatin
clearly indicated a cooperative self-association of the mem-
brane-bound antibiotic in gel-phase lipids.
EXPERIMENTAL PROCEDURES
Materials
Nystatin (pharmaceutical grade) was a gift from Squibb Farmaceutica
Portuguesa through the courtesy of Dr. Horacio Santana, and it was stored
at -20°C with exclusion of light. All other chemicals were obtained from
commercial suppliers and were used without further purification. DPPC
was purchased from Avanti Polar Lipids (Birmingham, AL)) and acetic
acid, Tris(hydroxymethyl)aminomethane, NaCl, NaOH, HCI, and EDTA
were obtained from Merck (Darmstadt, Germany). Methanol was spectro-
scopic or gradient grade and was purchased from Merck. A stock solution
of Nystatin (-1 mM) was prepared in methanol and stored at -20°C.
Nystatin concentration was determined by ultraviolet (UV) absorption
(E304nm = 7.4 x 104 M-1 cm- 1 in methanol).
Analysis and purification of Nystatin
Thin-layer chromatography (TLC) of Nystatin was performed on precoated
silica gel plates (silica gel 60 TLC plates; Merck) according to Thomas
et al. (1981). Briefly, the eluent consisted of the lower phase of chloroform-
methanol-water (20:22:10, v/v/v). The plates were pre-run in the mobile
phase and were then dried at 100°C for 30 min before use. After devel-
opment in the dark, the plates were air dried and visualized either with UV
light or by exposure to iodine vapors. The spots detected were scraped and
the compounds were eluted from the silica with methanol. After a centrif-
ugation step, these samples were subjected to gradient elution high-perfor-
mance liquid chromatography (HPLC).
HPLC of Nystatin was performed on a Merck apparatus, which included
a L-6200A pump, a L-5025 column chamber in conjunction with a L-4500
photodiode UV array detector. The separations were performed on a
LiChrospher 100 RP-18 column (5 ,um, 4 mm ID X 25 cm; Merck) with
an identical pre-column (5 gm, 4 mm ID X 0.4 cm) at a flow rate of 0.7
ml/min, at 350C. The solvent composition for all gradient runs was adapted
from Thomas et al. (1981) and changed linearly from 60:40 methanol-5
mM sodium acetate (pH 5.8) buffer to 85:15 over a 30-min interval. Then
it was maintained at that composition for an additional period of 10 min,
and 40 min after injection the solvent composition was returned to 60:40.
The purity was calculated as the percentage peak area corresponding to
Nystatin divided by peak areas of total number of peaks in each chromato-
gram. For the semipreparative work, a 10 ,um, 10 mm ID x 25 cm column
also packed with LiChrospher 100 RP-18 was employed. The flow rate was
4 ml/min, and the effluents were manually fractionated and analyzed by
analytical HPLC in the previously described conditions.
The fast atom bombardment (FAB) mass spectra were obtained with a
Kratos MS-25RF instrument with the sample dispersed in a 3-nitrobenzyl
alcohol matrix.
Model membrane preparation
Small unilamellar vesicles (SUVs) were prepared by sonication. Briefly,
the dry lipid was dissolved in chloroform in a round-bottom flask and the
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solvent was first dried under a stream of N2 and then further evaporated
under vacuum for at least 5 h. The dried lipid was dispersed to the desired
concentration (1-5 mM) by adding the appropriate volume of 50 mM
Tris-HCl (pH 7.4) buffer with 10 mM NaCl and 0.2 mM EDTA and by
repeated vortexing at 50°C, well above the gel-to-liquid crystalline phase
transition temperature (T0) of the lipid. The resulting multilamellar disper-
sion was then sonicated until near-optical clarity using a Branson 250
sonicator with a standard flat tip. This process was interrupted periodically
for 1 min to prevent overheating of the solution. The total sonication time
was usually 30 min. After equilibration of the suspension at 50°C for 1 h
(for the "annealing" process (Lawaczeck et al., 1976) to take place), the
titanium particles released from the tip were removed by centrifugation at
10,000 X g for 15 min, at room temperature. The final lipid concentration
of the solution was determined by phosphorus analysis (McClare, 1971).
The sonicated vesicles were stored at room temperature if they were kept
overnight before use.
Absorption and steady-state
fluorescence measurements
Absorption spectra were measured at room temperature using a Jasco
V-560 spectrophotometer. Fluorescence intensities were measured with a
Spex F112A Fluorog spectrofluorometer with a double emission mono-
chromator and a thermostatted cuvette holder (± 1°C) using 0.5 cm path-
length quartz cuvettes. Unless otherwise stated, fluorescence intensities
were measured at 315 nm excitation and 415 nm emission wavelengths
with spectral bandwidths of 0.9 nm and 9.0 nm, respectively. These
conditions were chosen to minimize Nystatin photochemical degradation
during the fluorescence measurements. Stray light was reduced using a UV
bandpass filter SB-300 (Corion) in the exciting beam and a WG-360
(Corion) cut-off filter in the emission beam, except in steady-state anisot-
ropy measurements. Moreover, background intensities in Nystatin-free
samples due to the vesicles were subtracted from each recording of fluo-
rescence intensity. All the fluorescence measurements were carried out in
a right-angle geometry, and the geometry effect (Parker, 1968) was taken
into account when necessary. Correction of excitation and emission spectra
were performed using a rhodamine B quantum counter solution and a
standard lamp (Lackowicz, 1983), respectively.
The steady-state anisotropy, (r), defined by the relationship (Lackowicz,
1983)
Ivv - GIVHIvv= + 2GVH- l
was obtained by measuring the vertical and horizontal components of the
fluorescence emission with excitation vertical (IvV and IVH respectively)
and horizontal (IHv and IHH, respectively) to the emission axis. The G
factor (G = IHV/IHH) corrects for the transmissivity bias introduced by the
detection system. These measurements were made with Glan-Thompson
polarizers, and background intensities due to the lipid vesicles were always
taken into account.
Time-resolved fluorescence measurements
Fluorescence lifetimes were determined by the time-correlated single-
photon timing technique. The instrument (Farinha et al., 1994) uses a
nitrogen-filled flashlamp (Edinburgh Instruments, 1 19F) operated at 80
kHz as the excitation source. The excitation and emission wavelengths
(316 nm and 415 nm, respectively) were selected with Jobin-Yvon H-20
monochromators with typical bandwidths of 4 and 8 nm, respectively. To
avoid artefacts caused by stray light, a UG-1 1 (Newport) filter and a
WG-360 (Corion) filter were placed in the excitation and emission beams,
respectively. The emission light was detected at 90°by a Phillips XP2254B
cooled (-30°C) photomultiplier to reduce background noise. Decay curves
were collected into 1024 channels with 0.268 or 0.122 ns/channel resolu-
tion, and 104counts were accumulated in the peak channel. Data collection
was carried out using a solution of 1,4-bis(5-phenyl-1,3-oxazol-2-yl)ben-
zene in cyclohexane as a reference (T = 1.1 ns; Lampert et al., 1983), and
the 8-function convolution method (Zuker et al., 1985) was applied in data
analysis.
Fluorescence intensity decay curves were analyzed by nonlinear least-
squares regression, fitting the data to a sum of exponentials as expressed by
Eq. 2:
I(t) = I aie
i=l
(2)
where ai and Tr are the normalized amplitude (XIai = 1) and lifetime of the
ith decay component, respectively. The reduced x2 value and weighted
residuals with their autocorrelation were used as best-fit criteria. The range
of X2 values obtained was 1.0-1.3.
The mean lifetime, (T), is defined by Eq. 3:
(i) = aidD.=, ajTj (3)
and the fractional intensity, fJ, of the ith decay component is given by
aXTi (4)
Partitioning of Nystatin into the vesicles
The interaction of a compound with phospholipid vesicles is usually
followed by adding a liposome stock solution successively to an aqueous
solution of the molecule in study. After each addition, a spectroscopic
signal of the bound compound is measured to monitor the interaction.
However, the high susceptibility of Nystatin to photochemical degradation,
characteristic of compounds with tetraene chromophores (Morgan et al.,
1980), prevented us from following this methodology. Instead, several
dilutions of a stock solution of SUVs (-5 mM) with buffer were prepared.
Then, a constant volume from the Nystatin stock solution was injected into
each of these samples. The final volume of methanol in solution never
exceeded 1.5% of the total volume of each sample. After an incubation
time of 1 h in the dark and at room temperature, the fluorescence intensity
of each sample was measured as a function of the lipid/antibiotic ratio in
the conditions previously described (see Absorption and Steady-state Flu-
orescence Measurements, above). The partitioning experiments were car-
ried out at 21 ± 1°C and 45 ± 1°C, and the data were analyzed according
to Eq. 5 (see Appendix):
AImax[L]l- 1(Py) + [L](5
In this equation, AI = I - IO stands for the difference between the
fluorescence intensity of the antibiotic measured in the presence (1) and in
the absence of phospholipid vesicles (IO); Amean = AI - Io is the
maximum value of this difference, because Ih,, is the limiting value of I
measured upon increasing the lipid concentration, [L], of the solution; P is
the partition coefficient of the antibiotic between the aqueous and lipid
phases and y is the molar volume of the lipid. As the partitioning exper-
iments were carried out with SUVs, it was considered that only 60% of the
overall lipid used was available for the initial partition of the antibiotic
(Beschiaschvili and Seelig, 1990); this is equivalent to the fraction of lipid
present in the outer leaflet of the bilayer. The molar volumes of DPPC in
SUVs in the gel (y = 0.828 dm3mol- ) and liquid-crystalline (y = 0.949
dm3moIl-) phases were estimated as described in Castanho et al. (1995).
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RESULTS
Characterization of Nystatin complex
Nystatin is an antibiotic produced by Streptomyces noursei,
which is known to be a complex mixture of closely related
compounds (Kleinberg and Finkelstein, 1984). The compo-
sition of Nystatin includes at least three tetraene antibiotics,
namely Nystatin A1 (which is considered to be the main
component of pharmaceutical-grade Nystatin), A2, and A3
(Zielinski et al., 1988). Kleinberg and Finkelstein (1984)
showed that the minor tetraene components present in their
Squibb Nystatin samples (accounting for nearly 20% of the
mixture) did not present any activity in their assays with
asolectin/ergosterol (2.5:1) membranes. The presence of a
small heptaene contaminant in Nystatin complex has also
been reported (Kleinberg and Finkelstein, 1984). These two
classes of polyene antibiotics are easily distinguished via
their absorption spectra, because the tetraene typically
shows absorption maxima in ethanol at 292, 305, and 320
nm, whereas the heptaene absorption maxima are at 364,
383, and 408 nm (Petersen, 1985).
The partial separation of the Nystatin complex was
achieved by HPLC (Fig. 2). The chromatogram shows the
presence of one major tetraene component (peak 1) and two
unresolved lesser components (peak 2). Based on the mea-
surement of peak areas, the main component comprised
82.0%, whereas the second peak accounted for 16.3% of the
total area. Moreover, two small heptaene impurities could
be separated from the Nystatin complex (peaks 3 and 4).
From the absorption spectra of Nystatin, these heptaene
contaminants were estimated to be approximately 2 mol%
if a molar absorptivity equivalent to AmpB was used
(Petersen, 1985).
The FAB mass spectra of Nystatin complex showed
molecular ions at m/z 948 [M + Na] +, 926 [M + H] +, and
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FIGURE 2 Separation of Nystatin complex by gradient HPLC. A Li-
Chrospher RP-18 column was eluted at a flow rate of 0.7 ml/min, at 35°C
with a 30-min duration linear solvent gradient starting from an initial 60%
A/40% B and ending with a 85% A/15% B solvent mixture (solvent A,
methanol; solvent B, 5 mM sodium acetate (pH 5.8) buffer). The final
solvent mixture was run for 10 min, and 40 min after injection the solvent
composition was returned to 60:40. Peaks (1), and (2), tetraene compo-
nents; peaks (3), and (4), heptaene components.
908 [(M + H) - H20]+. Because these peaks are close to
those expected for Nystatin A,, this must be the major
component of the complex used (peak 1 of Fig. 2).
The heptaenes and some minor tetraene contaminants
could be successfully separated from the main tetraene
components of Nystatin by TLC. However, a posterior
analysis by HPLC of the partially purified samples showed
that the ratio between the two main tetraene peaks 1 and 2
decreased relative to the parent complex. This unexpected
result, which implied an enrichment of the sample by the
components present in peak 2, could be explained by a
preferential retention of the main component of Nystatin by
the silica. A similar result had already been described for
another polyene antibiotic, Filipin (Kelly and Nabinger,
1985). Because we were interested in the opposite effect, we
did not proceed with this technique.
A semipreparative purification of Nystatin by HPLC was
also tried, but the complete elimination of peak 2 was not
achieved. These partially purified Nystatin samples were
used later in the time-resolved fluorescence experiments
and gave results (decay components) identical to the ones
obtained with the parent mixture.
These observations, together with the fact that all of the
major components of the Nystatin complex are tetraenes
(i.e., they have identical absorption properties) and that the
heptaenes are nonfluorescent molecules (Petersen and
Henshaw, 1981), prompted us to use the Nystatin complex
in the subsequent experiments.
Self-association of Nystatin in buffer and
in methanol
Solutions of Nystatin in 50 mM Tris-HCl (pH 7.4) buffer
with 10 mM NaCl and 0.2 mM EDTA were prepared from
dilution of a stock solution of Nystatin in methanol. To
detect the possible aggregation of the antibiotic, its fluores-
cence intensity and steady-state anisotropy were measured
as a function of antibiotic concentration in buffered solution
(Fig. 3). It should be noted that the precision of the anisot-
ropy measurements was low because of the negligibly small
quantum yield of Nystatin in aqueous solution (4 < 0.003;
Castanho et al., 1992). At low concentrations of Nystatin,
the anisotropy increased with the concentration of antibiotic
in solution; however, above -3 ,uM antibiotic the anisot-
ropy reached a maximum of 0.28 ± 0.03 and became
concentration-independent. At this antibiotic concentration,
there was also a sharp increase in the fluorescence intensity
of Nystatin. These observations are consistent with an ag-
gregation of the antibiotic in aqueous solution, a process
that was previously described (Castanho et al., 1992). In this
former study, it was also shown that the self-association of
the antibiotic in solution was accompanied by an increase in
the vibrational resolution of its emission spectra and in the
light-scattering intensity of the solution.
The same study was repeated in methanol (results not
shown). In this solvent, Nystatin fluorescence intensity
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FIGURE 3 Variation of the steady-state fluorescence anisotropy, (r) (0)
and fluorescence intensity, I (@) (Aexc = 304 nm; Aem = 410 nm) with
Nystatin concentration in 50 mM Tris-HCI (pH 7.4) buffered solution with
10 mM NaCl and 0.2 mM EDTA.
showed a linear dependence with concentration (0-25 ,uM).
On the other hand, the light-scattering intensity of the so-
lution was nearly constant within this concentration range of
antibiotic, showing a steep increase only for Nystatin con-
centrations larger than 100-200 ,uM (results not shown).
These results indicate that the antibiotic is virtually mono-
meric in methanol until it reaches this high concentration in
solution.
Fluorescence spectra of Nystatin
To gain insight into the interaction between Nystatin and the
phospholipid bilayer vesicles of DPPC, we investigated the
changes in the fluorescence properties of the antibiotic in
the presence of SUVs. Fig. 4 shows the normalized and
corrected emission spectrum of 6.5 ,iM Nystatin in buffer
and its normalized and corrected excitation and emission
spectra in the presence of 3 mM small unilamellar vesicles
of DPPC, at 21°C and 45°C. The excitation spectrum of
self-associated Nystatin in aqueous solution presents three
maxima at 293 nm, 306 nm, and 321 nm and a shoulder at
282 nm (not shown in Fig. 4 for the sake of clarity). Upon
the addition of phospholipid vesicles in gel (T = 21°C) or
liquid-crystalline phases (T = 45°C) to this solution, this
spectrum underwent a redshift of 1 nm, and it was found to
be essentially independent of the temperature of the sample.
On the other hand, the emission spectrum of Nystatin at
21°C was less broad and gained spectral resolution when
compared to the one obtained for Nystatin in buffer. Fur-
thermore, the fluorescence intensity of Nystatin was greatly
enhanced, as shown by the higher signal-to-noise ratio of
the first spectrum relative to the second one. In contrast, a
much less pronounced increase in Nystatin fluorescence
intensity could be observed upon its interaction with the
lipid vesicles above the gel-to-liquid-crystalline phase tran-
sition temperature of DPPC (Tc = 41°C) (see also Fig. 5).
At 45°C, the wavelength of maximum fluorescence inten-
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FIGURE 4 Normalized and corrected fluorescence spectra of 6.5 JIM
Nystatin...... Excitation spectra in the presence of 3 mM SUVs of DPPC,
at 21°C (Aem = 415 nm). , Emission spectra in buffer (50 mM
Tris-HCI, pH 7.4, with 10 mM NaCl and 0.2 mM EDTA) and in the
presence of 3 mM SUVs of DPPC prepared with the same buffer at 21°C
(---) and at 45°C (-m-) (Aexc = 315 nm).
sity of Nystatin underwent a redshift relative to 21°C (from
408 to 426 nm), and the Nystatin emission spectrum lost
vibrational resolution, presenting now a closer resemblance
with the spectrum obtained for Nystatin in aqueous solution.
Altogether these results indicate that Nystatin interacts with
the phospholipid vesicles at both temperatures. Moreover,
no alterations were observed either in the excitation or in the
emission spectra of Nystatin as a function of antibiotic
concentration in the presence of the lipid vesicles, at both
temperatures.
Nystatin binding to the lipid vesicles
The increase in the fluorescence intensity of Nystatin asso-
ciated with the interaction between the antibiotic and the
lipid vesicles was used to measure its partition into SUVs of
DPPC, both in gel and in liquid-crystalline phases. Fig. 5
shows the enhancement in Nystatin fluorescence for sam-
ples in which the antibiotic concentration was kept constant
while the lipid concentration was varied. This study could
not be carried out using high concentrations of Nystatin and
lipid, because of the detected fusion/aggregation of the
vesicles induced by the binding of the antibiotic. This pro-
cess was noticed by the increase in the baseline of the
absorption spectra of the antibiotic in the presence of the
lipid vesicles relative to a control turbidity spectrum mea-
sured with an antibiotic-free lipid solution. This increase
was particularly pronounced when the lipid vesicles were in
the gel phase and for antibiotic concentrations greater than
approximately 9 ,uM. In those conditions, the presence of
larger light-scattering particles in solution reduced the trans-
mitted light and thus caused the fluorescence intensity of
Nystatin to decrease suddenly when the ratio of lipid to
antibiotic in solution was increased. Therefore, low concen-
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FIGURE 5 Enhancement of the fluorescence intensity of Nystatin upon
increasing the lipid concentration in solution (SUVs of DPPC) (a) at 210C
and (b) at 45°C. The Nystatin concentrations used were (0) 4.2 ,uM, (A)
6.5 ,uM, (X) 7.8 ,uM, and (*) 13.5 ,uM. [Lipid], accessible lipid concen-
tration = 60% of total lipid concentration. Error bars represent the standard
deviation of duplicate or triplicate measurements at the indicated lipid
concentration. The full curves are nonlinear least-squares fittings of Eq. 5
to the data points, which were used to yield estimates of the partition
coefficients, P. The dashed curves are displayed just to show the poorer
fittings obtained for these two antibiotic concentrations.
trations of Nystatin were used in this study at 21°C. Ac-
cording to the model proposed (see Appendix), the fluores-
cence intensity data obtained for 4.2 ,uM Nystatin at 21°C
(Fig. 5 a) were fitted to Eq. 5 to yield estimates of AImax and
P. The partition coefficient thus obtained was (1.4 ± 0.1) X
103. The same procedure was also followed with the data
obtained for 6.5 and 7.8 ,uM antibiotic, but a hyperbolic
curve, as the one predicted by Eq. 5, could not adequately
describe the experimental results, as judged by the poorer
fits obtained in these cases (Fig. 5 a). It should be noted,
especially for 7.8 ,uM antibiotic, that the increase in its
fluorescence intensity leveled off toward a plateau almost
abruptly at a lipid concentration around 1.5 mM. This result
suggests that some antibiotic was being retained in the
aqueous phase even if the lipid phase was further extended,
indicating that for these antibiotic concentrations a more
complex model than the one presented in the Appendix is
needed to describe the partitioning of the antibiotic into the
lipid vesicles.
The partitioning study of Nystatin was also carried out
with the phospholipid vesicles above Tc. At 45°C, the scat-
tering artifacts caused by the vesicles were less critical and
higher Nystatin concentrations could be used. At this tem-
perature, the binding curves were far from reaching a pla-
teau within the lipid concentration range accessible to this
experimental study (Fig. 5 b). This result indicates that the
interaction between the antibiotic and the phospholipid ves-
icles was weaker in the liquid-crystalline phase; in fact, a
lower partition constant of (2.9 ± 1.0) X 102 was estimated
for Nystatin by the fitting procedure previously described.
Steady-state fluorescence
anisotropy measurements
The steady-state fluorescence anisotropy of Nystatin as a
function of total lipid concentration in solution is plotted in
Fig. 6 a. These measurements were performed either by
adding several aliquots of 5 mM SUVs of DPPC to aqueous
solutions of Nystatin or by direct injection of a Nystatin
stock solution into the lipid vesicles. Therefore, the final
concentrations of both antibiotic and lipid were varyied for
each series of measurements. At 21°C, the limiting anisot-
ropy of Nystatin for diluted solutions of small unilamellar
vesicles of DPPC was estimated to be 0.33 ± 0.01, and it
was found to be independent of the lipid-antibiotic ratio
used. However, as the concentration of the lipid was in-
creased above approximately 2 mM, a gradual decrease in
the steady-state anisotropy of Nystatin was measured (Fig.
6 a). For a set of samples in which the concentration of the
lipid was kept constant and the final Nystatin concentration
in solution varied (Fig. 6 b), the anisotropy of the antibiotic
was found to be independent of the lipid-antibiotic ratio
used, although it progressively decreased for each set of
samples prepared with a higher lipid concentration (results
not shown).
These measurements were harder to perform at 45°C
because of the decrease in the fluorescence intensity of the
antibiotic at this temperature (see Fig. 5). Therefore, it was
possible to obtain reproducible values only for total lipid
concentrations greater than 2.5 mM. Again, the anisotropy
of Nystatin was found to be independent of the lipid-
antibiotic ratio used, and a constant value of 0.31 ± 0.03
was measured for its limiting anisotropy (results not
shown).
Time-resolved fluorescence measurements
Gel phase
The fluorescence intensity decay curves measured for 3.0
and 12.5 ,uM Nystatin in the presence of 3 mM sonicated
vesicles of DPPC at 21°C are shown in Fig. 7. As judged
from the fitting criteria (X2 value and random weighted
residuals and autocorrelation plots), the experimental data
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FIGURE 6 Variation with (a) total lipid concentration and (b) antibiotic
concentration in solution of the steady-state fluorescence anisotropy, (r), of
Nystatin in SUVs of DPPC at 21°C. (a) The samples were prepared by
titrating (O) 7.1 ,uM, (A) 14.2 ,tM, or (0) 21.3 ,uM antibiotic aqueous
solution with 5 mM SUVs of DPPC or (-) by direct injection of the
antibiotic stock solution to the lipid vesicles. The antibiotic concentration
varied from 4.9 to 14.6 ,uM in this last case. (b) [Lipid]t = 1 mM.
could be described by a sum of three exponentials (Table 1).
These curves also show a concentration dependence for the
emission decay kinetics of Nystatin upon its interaction with
lipid vesicles in a solid-like gel phase because 12.5 ,uM
antibiotic (Fig. 7 b) displays a longer-lived mean fluores-
cence lifetime than 3.0 ,uM (Fig. 7 a) (30.0 and 11.7 ns,
respectively). To further characterize this dependence, sev-
eral fluorescence decay curves were obtained with different
Nystatin final concentrations (solutions prepared with a
fixed lipid concentration of 3 mM). Fig. 8 shows the fluo-
rescence decay parameters of Nystatin recovered from one
set of those experiments. Several features of these values are
noteworthy. Upon increasing Nystatin concentration in so-
lution, there was a sharp increase in the amplitude of the
longest-lived decay component (a), from approximately
0.03 to 0.25, at an antibiotic concentration of about 5-6 ,uM
(Fig. 8 a). An opposite change occurred with the normalized
pre-exponential associated with the intermediate lifetime
(a), which decreased sharply from nearly 0.40 to 0.28 in
the same antibiotic concentration range. On the other hand,
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FIGURE 7 Time-resolved fluorescence intensity of (a) 3.0 ,mM and (b)
12.5 ,uM Nystatin in the presence of 3 mM SUVs of DPPC, at 21'C (AeXc
= 316 nm; Aem = 415 nm). Both the fluorescence response of 1,4-bis(5-
phenyl-1,3-oxazol-2-yl)benzene and the experimental and calculated pat-
terns of the antibiotic are shown (1024 channels; time resolution, 0.268
ns/channel). The three-component fits to the data were: (a) a1 = 0.56; T1
= 1.7 ns; a2 = 0.41; T2 = 7.1 ns; a3 = 0.03; T3 = 34.1 ns; x2 = 1.099;
and (b) a, = 0.50; T, = 2.4 ns; a2 = 0.29; T2 = 10.2 ns; a3 = 0.21; T3 =
38.3 ns; x2= 1.194. The goodness of fit is demonstrated by the weighted
residuals plots.
the amplitude associated with the shortest lifetime (a,)
showed a gradual decrease in its value from about 0.58 to
0.46. Concomitantly with these alterations, both the longest
and intermediate lifetimes (T3 and T2, respectively) in-
creased slightly with Nystatin concentration, whereas the
shortest lifetime (1i) remained essentially concentration in-
dependent (Fig. 8 b). As a consequence of these changes,
the intensity-weighted mean lifetime of Nystatin (Fig. 8 c)
displayed an almost steplike enhancement from nearly 11 to
33 ns at an antibiotic concentration of approximately 5-6
,uM. This increase resulted primarily from the contribution
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TABLE I Fluorescence intensity decay parameters of Nystatin in small unilamellar vesicles of 3 mM DPPC as a function of Ny-
statin concentration and temperature
T (0C) [Nystatin]§ (,aM) a, Tr (ns) a2 T2 (ns) a3 T3 (ns)
21* 3.0 (8) 0.55 2.4 0.41 8 0.03 33
10.5 (3) 0.55 2.9 0.24 14 0.21 42
12.5 (4) 0.50 2.4 0.30 11 0.21 37
45t 2.3-16.0' (7) 0.75 1.2 0.25 4.2
a1 and Ti are the average values of the normalized amplitude and lifetime, respectively, of each decay component, for n decay measurements.
* a1, ±0.04; TI, ±0.7; a2, ±0.05; T2' ±3; a3, ±0.05; T3, ±5 ns.
a1, ±0.02; TI, ±0.1; a2, ±0.02; T2' ±0.2 ns.
§ The values in parenthesis indicate the number, n, of measurements.
¶ The decay components were independent of Nystatin concentration.
of the longest lifetime component, whose fractional inten-
sity (calculated from Eq. 4) increased from approximately
0.17 to 0.63.
Because the precision associated with the decay param-
eters of Nystatin was low (see Table 1), a study of the
reproducibility of the change in the emission decay kinetics
of Nystatin was carried out. Fig. 9 shows that the sharp
transition measured for the Nystatin mean fluorescence life-
time always occurred within a narrow range of antibiotic
concentrations (between 5 and 7 ,uM). Moreover, the par-
tially purified Nystatin samples by HPLC also exhibited the
same trend of variation in their decay parameters upon
varying the antibiotic concentration in solution. The addi-
tion of Nystatin methanolic solution to the suspension of
vesicles at 45°C instead of 21°C (i.e., above the phase
transition temperature of DPPC) also had no influence on
Nystatin fluorescence intensity decays measured subse-
quently at 21°C.
These results indicate that the tetraene fluorophore of
Nystatin is experiencing a different environment in the lipid
bilayer as its total concentration in solution exceeds 5-6
,uM. Furthermore, the critical behavior shown by the decay
parameters of Nystatin suggests that a cooperative transition
is taking place, which is only compatible with the antibiotic
undergoing a self-association in the membrane. Strong ev-
idence for the presence of Nystatin aggregates in the lipid
vesicles was provided by a simple experiment. This con-
sisted of submitting a sample of lipid vesicles with pre-
incorporated antibiotic to a brief sonication pulse. The flu-
orescence intensity decay of Nystatin was measured prior to
and after this treatment, and conversion of the slow decay-
ing to the fast decaying species was observed, suggesting
that the sonication pulse disrupted the aggregates of Ny-
statin. The possibility of Nystatin degradation during this
experiment was ruled out by performing a careful fluores-
cence characterization of the sample before and after this
procedure.
Two additional experiments were carried out to obtain
more information about the formation of these strongly
fluorescent antibiotic aggregates. First, a sample of lipid
vesicles pre-incubated with Nystatin (13.7 ,uM) and exhib-
iting a typical long mean lifetime was diluted with buffer to
an antibiotic final concentration of 4.6 ,tM. After a short
incubation period, the emission decay kinetics of Nystatin
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FIGURE 8 The concentration dependence of the fluorescence decay
parameters of Nystatin in 3 mM SUVs of DPPC. (a) Normalized ampli-
tudes, ai and (b) fluorescence lifetimes, Ti of the (0) short-, (-) interme-
diate-, and (LI) long-lived decay components of Nystatin at 21°C, respec-
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was found to remain constant. However, if the dilution
procedure was repeated using SUVs (at the same initial lipid
concentration) instead of buffer, the fluorescence intensity
decay of Nystatin changed into one characteristic of a
4.6 AM sample. These results suggest that the removal of
Nystatin from the membrane to the aqueous phase follows a
slow kinetics. On the other hand, the exchange of antibiotic
molecules between the lipid vesicles must be a very fast and
predominantly intervesicular process, causing the dissocia-
tion of the aggregates.
Liquid-crystalline phase
Results of a three-component and two-component analysis
of the fluorescence intensity decays of 9.6 ,AM Nystatin in
3 mM DPPC bilayers are shown in Fig. 10 as a function of
temperature. Above the DPPC phase transition temperature,
no contribution from the longest lifetime component to the
fluorescence decay could be detected (Fig. 10 a), and
the fluorescence decays of the antibiotic were now satisfac-
torily fitted by a biexponential instead of a three-exponen-
tial function, as revealed by the low x2 values obtained and
by the random distribution of the weighted residuals (results
not shown). The abrupt variations observed in the pre-
exponential factors of the shortest and intermediate-lifetime
components at Tc are a consequence of this change in the
analysis function of the emission decay kinetics of the
antibiotic (Fig. 10 a). Both the intermediate and longest-
lived lifetime components could detect the phospholipid
thermotropic phase transition temperature, as evidenced by
the steep change in their magnitude at -41°C (Fig. 10 b). In
contrast, the shortest lifetime component of the fluorescence
decay of Nystatin was almost temperature independent (Fig.
10 b) and did not sense this transition.
The fluorescence decay parameters obtained for a final
antibiotic concentration in solution lower than the critical
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FIGURE 10 Variation with temperature of the fluorescence decay pa-
rameters of 9.6 ,uM Nystatin in 3 mM SUVs of DPPC. (a) Normalized
amplitudes, ai; (b) fluorescence lifetimes, Ti of the (0) short-, (i) inter-
mediate-, and (O) long-lived decay components, respectively; (c) A, mean
excited-state lifetime, (r) (see the legend of Fig. 8) of Nystatin. It should
be noted that above 41'C the fluorescence decays were fitted to a two-
exponential function.
concentration range previously described (5-7 ,uM) showed
a similar temperature dependence. Furthermore, the decay
parameters of Nystatin were found to be concentration
independent at 45°C within the concentration range studied
(0-14 ,uM) (Fig. 8 and Table 1).
DISCUSSION
Characterization of Nystatin complex
The structure of Nystatin Al, the main component of
Nystatin complex, has been elucidated (Borowski et al.,
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1971) (Fig. 1), and it was shown to contain a glycosidally
linked mycosamine at C- 19. Another constituent of Nystatin
complex, Nystatin A3, contains digitoxose as an additional
neutral sugar at C-35 (Zielinski et al., 1988). No information
could be found relative to Nystatin A2 except that it has a
molecular ion [M + H] + with a m/z value lower than that of
Nystatin Al (910 and 926, respectively (Mitrofanova et al.,
1991)). Because this component has the same sugar but it is
less polar than Nystatin A1 (Manwaring et al., 1969), we
conclude that their chemical structures must differ in the
number of hydroxyl groups present in the lactone ring.
The aim of this study was to perform a photophysical
characterization of Nystatin to obtain structural information
on its interaction with model membranes, and so it was
important to guarantee the purity of the antibiotic samples
used. The gradient HPLC analysis showed that all of the
major components of this antibiotic complex were tetraenes
and that the heptaene contaminants accounted for only 2
mol% of the sample. Because these last compounds are
nonfluorescent (Petersen and Henshaw, 1981), its small
content in the antibiotic complex should not interfere with
our measurements. Another potential problem related to the
use of nonpurified antibiotic is the presence in the sample of
molecules with the same fluorophore but which establish
distinct interactions with the lipid bilayers, e.g., Nystatin A1
and A3, because of their different chemical structures. Al-
though the only structural difference between these two
compounds is the additional digitoxose in Nystatin A3, this
second sugar moiety may produce different membrane lo-
cations and therefore cause distinct photophysical behaviors
for these two antibiotic molecules. However, the molecular
ion of Nystatin A3 (m/z 1056 [M + H] + (Zielinski et al.
(1988)) was not detected in the FAB mass spectra of Ny-
statin complex and hence it must be present in a very small
amount in our samples, if at all. After certifying that the
partially purified Nystatin samples by HPLC and the parent
mixture had identical photophysical properties in lipid bi-
layers, this study was then safely carried out with the
Nystatin complex.
The aggregation of Nystatin in
homogeneous media
The fluorescence intensity data (Fig. 3) clearly showed that
Nystatin at concentrations higher than 3 ,uM is forming
aggregates in aqueous solution that have a larger quantum
yield than monomeric antibiotic, in agreement with what
was reported in a preliminary study (Castanho et al., 1992).
The steady-state fluorescence anisotropy of Nystatin con-
firmed this conclusion, since its increase is further evidence
for the formation of larger antibiotic species in solution as
the antibiotic concentration was raised. This reasoning is
based on the expectation that the lifetime of the aggregate
must be longer than the one of the monomer because of the
measured increase in its quantum yield. The fluorescence
sured accurately because of the time resolution of our in-
strumentation, an upper limit of approximately 100 ps being
reported in the literature (Petersen et al., 1987). This exper-
imental difficulty also prevented us from estimating the
volume of the aggregate by application of the Perrin and
Stokes-Einstein equations in a simple approximation (spher-
ical geometry; Lackowicz, 1983) to the steady-state anisot-
ropy data. Nevertheless, if we admit that the fluorescence
lifetime of the aggregate is independent of Nystatin concen-
tration in solution, the constant value measured for its
steady-state anisotropy above 3 ,uM suggests that it has also
a constant correlational time or, in other words, a constant
volume. Accordingly, the anisotropy data are consistent
with a micellization-type equilibrium of the antibiotic in
aqueous solution with a critical concentration of approxi-
mately 3 ,uM.
In methanol, the fluorescence intensity data showed that
the molecule exists as a monomer in solution, irrespective of
its concentration within the range studied (0-25 ,uM). The
formation of oligomers, detected by the increase in the
light-scattering intensity of the solution, was only notice-
able for antibiotic concentrations larger than 100 ,uM.
The chemical structures of Nystatin and AmpB show a
close resemblance, both molecules having a hydrophobic
side with their polyene chains, and a hydrophilic side with
several polar substituents (Fig. 1). Besides this lateral asym-
metry, which confers on these molecules their amphiphilic
character, most of their hydroxyl groups are positioned
axially on the same side of the plane of the lactone ring,
together with the mycosamine moiety. These characteristics
make the antibiotics very poorly water soluble and only
moderately soluble in organic solvents. The formation of
aggregates of polyene antibiotics in different solvents had
previously been studied by several techniques, namely elec-
tronic absorption, circular dichroism, light scattering, and
nuclear magnetic resonance (Rinnert et al., 1977; Mazerski
et al., 1990; Balakrishnan and Easwaran, 1993b). The ag-
gregation behavior found for Nystatin is in agreement with
the former studies carried out with AmpB, which showed
that this last antibiotic exists monomerically only in polar
organic solvents (methanol, ethanol, dimethylformamide,
and dimethylsulfoxide). In particular, for a phosphate buff-
ered saline (pH = 7.4) solution, a CD study of Nystatin
showed that this antibiotic self-associated at a critical con-
centration of 10 ,uM (Bolard et al., 1991). Considering that
this study was carried out at a different temperature (37°C)
and that this process is strongly dependent on the tempera-
ture, among other factors (Bolard et al., 1991), there is a
reasonable agreement between the two results.
Fluorescence spectral alterations of Nystatin
The blueshift undergone by the fluorescence emission spec-
tra of Nystatin upon adding lipid vesicles to the solution, at
either 21°C or 450C (Fig. 4), demonstrated unequivocally
lifetime of Nystatin in aqueous solution could not be mea-
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that the antibiotic molecules interacted with the lipid bilay-
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ers at either temperature and that their fluorophores were
experiencing a less polar environment. This effect was more
pronounced for the vesicles in a gel phase because concom-
itantly to this shift the emission spectrum of the antibiotic
also increased its vibrational structure. These changes are
also compatible with the inclusion of the chromophore in a
more rigid environment because this behavior had previ-
ously been detected upon the formation of large antibiotic
aggregates in the aqueous phase (Castanho et al., 1992) and
upon decreasing the temperature of an ethanolic solution of
Nystatin to 77 K (Bel'kov and Bondarev, 1987). Curiously,
the emission spectrum of Nystatin in fluid-like phospholipid
vesicles displayed a close similarity to its aqueous fluores-
cence emission, except that it was less broad.
The spectroscopic properties of Nystatin may be com-
pared with those of t-PnA, a naturally occurring 18-carbon
fatty-acid which has also a conjugated all-trans-tetraene
chromophore. It should be taken into consideration, how-
ever, that apart from their polyene chains these two mole-
cules have very different chemical structures that may in-
fluence their absorption and fluorescence properties as well
as the chromophore location in the lipid bilayer. Thus, 1) the
fluorescent group of Nystatin is inserted into a lactone ring,
which must introduce constraints on its mobility, and 2) this
group is in close vicinity to a diene and to a glycosidic
linkage (Fig. 1). Finally, 3) the tetraene chromophore of
t-PnA is located near the terminal methyl group of its chain
because t-PnA is a 9,11,13,15-all-trans fatty acid. It has also
been recently shown (Castanho et al., 1995) that this group
is located deep inside the bilayer, whether the membrane is
in a gel or liquid-crystalline phase. On the other hand, the
tetraene group of Nystatin is positioned near its myco-
samine sugar, which is positively charged at the pH of our
experiments (Mazerski et al., 1990). Hence, it is very un-
likely that it has the same location as the chromophore of
t-PnA in a bilayer. Most probably the antibiotic must be
adsorbed at the bilayer surface or, if inserted vertically, its
tetraene group must nevertheless be in close vicinity to the
more polar region of the bilayer.
The absorption spectrum of t-PnA is blueshifted relative
to the one of cis-parinaric acids (Sklar et al., 1977a). Inter-
estingly, the absorption of Nystatin is identical to that ob-
tained for the cis and not for the trans fatty-acid isomer.
This is certainly due to the more complex structure of
Nystatin, where its all-trans chromophore may be partici-
pating in through-bond interactions with the diene chain and
adjacent oxygen, and therefore. it may be stabilized. Another
difference between Nystatin and t-PnA is the changes un-
dergone by their excitation spectra upon varying the envi-
ronment of their fluorescent chromophores. The excitation
spectrum of t-PnA exhibits a blueshift on going from the
higher density gel phase to the lower density liquid crystal-
line phase because of the increase of the medium polariz-
ability (Sklar et al., 1977b). It was even reported (Hudson
et al., 1986) that the environment of this probe can be
characterized in terms of its density by determining its
statin remained unchanged upon increasing the temperature
of the lipid vesicles above Tc. A possible explanation for
this result is the expected difference in the location of the
two chromophores in a lipid bilayer, as discussed above.
The shallower location anticipated for the antibiotic chro-
mophore in the lipid bilayer and its inclusion in a lactone
ring must prevent the establishment of a close contact
between it and the acyl chains of the surrounding phospho-
lipids. Consequently, it does not sense a significant varia-
tion of the refractive index of its micro-environment upon
varying the temperature of the system, which is at variance
with what was observed with t-PnA. In spite of these
differences between Nystatin and t-PnA, the equivalence
between their photophysical properties is so large that it
justifies the use of t-PnA as a model compound of Nystatin
fluorescence properties, as we shall discuss later.
Partition of Nystatin between phospholipid and
aqueous phases
The fluorescence enhancement of Nystatin was used to
assess its binding to the phospholipid vesicles. Because the
fluorescence intensity of Nystatin in aqueous solution is
almost negligible but becomes considerable when the probe
is included in a hydrophobic environment, this parameter is
a sensitive reporter of its partition into the bilayer vesicles.
The partition coefficients of Nystatin determined for small
unilamellar vesicles of DPPC in gel (T = 21°C) and liquid-
crystalline (T = 450C) phases were (1.4 ± 0.1) X 103 and
(2.9 ± 0.1) X 102, respectively. In spite of the low accuracy
of this last value owing to the experimental difficulty in
reaching a plateau in the fluorescence signal, these results
clearly show that the antibiotic has a higher binding affinity
for a more ordered, rigid-like lipid phase than for a fluid
one. Previous binding studies carried out with Nystatin and
AmpB and employing different techniques had also reached
the same conclusion (Abramson and Ockman, 1973; Bolard
et al., 1981; Jullien et al., 1988). It is worthwhile to note that
regardless of their hydrophobicity, these polyene antibiotics
do not partition into the lipid bilayers to a very large extent
when added from the aqueous phase because of their ability
to form water-soluble aggregates.
The results obtained in the partition study of 6.5 and 7.8
,uM antibiotic at 21°C showed a poorer agreement between
experimental data and the theoretical analysis derived in the
Appendix. This model considers exclusively the existence
of a single species in solution that may be incorporated into
a bilayer membrane according to a partition equilibrium.
However, we have previously shown that above a threshold
of around 3 ,tM antibiotic, Nystatin self-associates in aque-
ous solution and so, for these two antibiotic concentrations,
and particularly for 7.8 ,uM, aggregates of antibiotic must
be also present in solution. Hence, this more complex situ-
ation, which includes at least an additional aggregation
equilibrium in solution, is no longer adequately described
excitation maximum. Yet, the excitation spectrum of Ny-
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by our partition model. At 45'C, the critical concentration
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of Nystatin is shifted to a higher value (Bolard et al., 1991),
and thus the simple partition model derived in the Appendix
is now fulfilled in a wider Nystatin concentration range.
The fluorescence properties of Nystatin had already been
the subject of a thorough study, both in homogeneous so-
lution (Petersen, 1985) and phospholipid vesicles (Petersen
et al., 1987). Although our experimental results show es-
sentially a general agreement with those reported in those
studies, our interpretation is totally different from theirs on
several points. Petersen et al. (1987) reported that Nystatin
is quenched in bilayer membranes by a static process, the
quenching being equally efficient in both the gel and liquid-
crystalline phases of the bilayer. The main experimental
evidence presented in their study to support the existence of
a static quenching process was that Nystatin quantum yield
decreased while its average lifetime remained unchanged
for samples in which the total concentration of Nystatin was
kept constant and the phospholipid concentration was pro-
gressively decreased to a final 25-fold dilution. To explain
these results, Petersen et al. (1987) tried to fit their data to
a fluorescence resonance energy-transfer model (hetero-
transfer) in two dimensions (Snyder and Freire, 1982). We
think that their reasoning is totally inconsistent because
1) this mechanism of quenching predicts a decrease in the
fluorescence intensity as well as of the fluorescence lifetime
of the donor, which is incompatible with the results reported
by Petersen et al. 2) Energy migration (homotransfer), and
not heterotransfer, is the only possible interaction in a
system with only one component. This point will be dis-
cussed later in more detail. Finally, 3) Petersen et al. de-
scribed the model applied as dynamic, but its derivation did
not consider diffusional processes. Based in our previous
discussion, we propose a different explanation for their
results. As the phospholipid concentration in solution was
decreased, a smaller fraction of the overall antibiotic present
in each sample partitioned into the lipid phase. This implied
a decrease in the quantum yield of the antibiotic because
this parameter was evaluated relative to the overall antibi-
otic concentration in solution and not only relative to the
fraction partitioned into the lipid bilayer. On the other hand,
Nystatin fluorescence lifetime did not vary because this
antibiotic is almost nonfluorescent in the aqueous phase. In
fact, if we re-analyze the results of Petersen et al. (1987)
presented in their table 3 according to our partition model
(see the Appendix), we obtain a satisfactory fit, and a
partition constant of 2.3 X 103 is estimated, admitting that
both layers of the model system of membranes are accessi-
ble to the antibiotic incorporation. This result is in reason-
able agreement with our own determinations, considering
that different experimental conditions were used in each
case, namely distinct model systems of membranes (small
unilamellar vesicles prepared by sonication versus ethanol
injection), phospholipids (DPPC versus 1, 2-dimyristoyl-sn-
glycero-3-phosphocholine), and buffers (50 mM Tris-HCl,
pH 7.4, with 10 mM NaCl and 0.2 mM EDTA versus
phosphate-buffered saline, pH 7.4). Moreover, it should also
tetraene upon its binding to hydrophobic sites is a general
property of this fluorophore. In fact, it had already been
used extensively to study the binding of Lucensomycin,
another tetraene-containing polyene antibiotic with a
smaller (C25) lactone ring, to erythrocyte ghosts (Strom
et al., 1976), the binding of t-PnA to hydrophobic sites in
proteins (Sklar et al., 1977c; Berde et al., 1979), and the
partition of this fatty acid into lipid vesicles (Sklar, 1980).
The main conclusion of the study by Petersen et al.
(1987) was that the fluorescence of Nystatin was quenched
in a static process through the formation of antibiotic ag-
gregates within the lipid bilayer. These were nonfluores-
cent, at variance with the monomeric antibiotic species.
However, the demonstration of a static quenching process
requires different experimental planning to discard aqueous/
lipid partitioning effects. Thus, the samples should be pre-
pared with the same amount of lipid and a varying Nystatin
concentration to ensure a constant fraction of antibiotic in
the membrane bilayer. By following this experimental pro-
cedure, we obtained a fluorescence signal linearly depen-
dent on the total antibiotic concentration added to the lipid
solution. Besides an irreversible photochemical dimeriza-
tion reaction (Morgan et al., 1980), the only other report that
we found in the literature of a self-quenching process for a
derivative of t-PnA was a study by Somerharju et al. (1981).
These authors synthesized a phospholipid containing a cis-
parinaroyl moiety at the sn-2-position and found that lipid
vesicles prepared exclusively with this probe displayed a
very low fluorescence. The self-quenching process of this
probe occurred with a 50% efficiency for vesicles contain-
ing approximately 10 mole% of labeled phosphatidylcho-
line (Somerharju et al., 1983). This value should be com-
pared with the results of Petersen et al. (1987) (Fig. 3),
which show an almost 100% quenching efficiency at a
Nystatin-to-lipid ratio of only 0.02. In conclusion, we think
that the explanation for the quenching of Nystatin quantum
yield measured by these authors is a variable binding of the
antibiotic to the lipid vesicles within the phospholipid con-
centration range used by Petersen et al. (1987), and not the
formation of nonfluorescent Nystatin complexes.
Steady-state fluorescence anisotropy of Nystatin
The limiting anisotropies of Nystatin determined for infinite
lipid dilution were (r) = 0.33 + 0.01 and (r) = 0.31 + 0.03
for SUVs of DPPC in solid-like gel and fluid-like liquid-
crystalline phases, respectively, in agreement with a previ-
ous report (Petersen et al., 1987). In contrast, the steady-
state fluorescence polarization of t-PnA showed a sharp
decrease at the temperatures corresponding to phase
changes in the lipid bilayer (Sklar et al., 1977b). Although
the temperature dependences of the mean lifetimes of Ny-
statin and t-PnA are rather similar, at least for antibiotic
concentrations larger than 6 ,uM (see next section), their
anisotropy behaviors are quite distinct. This difference must
be stressed that the increase in the quantum yield of a
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be then related to the chemical structures of these two
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compounds and eventually to their different locations in the
lipid bilayer. Whereas Nystatin is a bulky molecule, t-PnA
is a fluorescent probe with a structural similarity to the acyl
chains of the phospholipids. Hence, the large size of Ny-
statin must prevent this molecule from reorienting its tran-
sition dipole in the bilayer during its excited-state lifetime,
even when it is present in a more fluid environment such as
a lipid bilayer in a liquid-crystalline phase.
Petersen et al. (1987) measured a decrease in Nystatin
steady-state fluorescence anisotropy at high Nystatin densi-
ties in the bilayer vesicles. For this set of experiments, these
authors used a constant phospholipid concentration while
the Nystatin concentration was changed. We were not able
to reproduce their results because the only way we suc-
ceeded in measuring a decrease in Nystatin anisotropy was
by increasing the lipid concentration in solution (Fig. 6 a).
In those conditions, it is well known that the source of the
anisotropy decrease is artifacts caused by the scattering
properties of the lipid vesicles (Lentz et al., 1979). Even
admitting that the anisotropy measurements obtained by
Petersen et al. are not hampered by this artifact, we think
that their interpretation is again subject to strong criticism.
These authors tried to explain their experimental results
using now an energy-transfer model for homotransfer in two
dimensions (Snyder and Freire, 1982). The only interaction
that may cause a decrease in the fluorescence polarization of
a fluorophore upon increasing its concentration is indeed
energy migration (homotransfer). In fact, this experimental
observation and an invariance of the fluorophore lifetime
and steady-state fluorescence intensity with its concentra-
tion, are used as criteria to confirm the existence of this kind
of interaction. But, more importantly, as with any other
dipolar energy transfer process between a donor and an
acceptor molecule, an essential requisite for its occurrence
is the existence of a substantial spectral overlap between the
emission and absorption spectra of the two molecules, re-
spectively. This can hardly be the case with Nystatin, as can
be judged from Fig. 3. Because of the specific photophysics
of tetraenes (Hudson and Kholer, 1974), namely the fact
that their absorption and emission properties are determined
by transitions between different electronic states (absorp-
tion: S2<-So; emission: SI->So), Nystatin absorption and
emission spectra are clearly distinct and widely separated,
showing almost no overlap between them. This implies that
the Forster radius, RO, for the Nystatin-Nystatin pair should
be very low and certainly never be equal to 4.5 nm, the
value recovered by Petersen et al. (1987) in their fitting of
the energy migration model to the anisotropy data. Hence,
energy migration must be a very inefficient process for
Nystatin and cannot be the explanation for the decrease
measured by Petersen et al. (1987) for the anisotropy of this
antibiotic. Beyond a bias introduced in their measurements
due to an increased light-scattering of the solution (e.g.,
caused by a variation in the lipid vesicles properties, namely
their size, induced by an increased content of Nystatin in the
bilayer), we do not envisage other hypothesis to explain
their experimental results.
Self-association of Nystatin in lipid vesicles
Before proceeding with the discussion, some photophysical
properties of t-PnA will be briefly reviewed because they
are a determining factor in the interpretation of our exper-
imental results. It has now been unequivocally shown using
the maximum entropy method that even in homogeneous
solution (like ethanol, cyclohexane, and paraffin oil) t-PnA
displays a complex emission decay kinetics described by a
bimodal fluorescence lifetime distribution (Mateo et al.,
1993). This same pattern is followed by this probe in lipid
bilayers well above their thermotropic transition tempera-
ture. However, near this temperature and below, a third
lifetime component centered at higher values appears that
was interpreted as corresponding to the emission of the
probe localized in the gel phase (Mateo et al., 1993). There-
fore, the fluorescence kinetics of this fatty acid is extremely
sensitive to changes in the density of its close environment.
Results similar to these had previously been found by using
different methods of fluorescence decay analysis that con-
sidered either a sum of discrete lifetimes (Ruggiero and
Hudson, 1989) or an a priori defined lifetime distribution
(James et al., 1987).
The changes measured in the fluorescence intensity decay
kinetics of Nystatin with temperature, when the antibiotic
was partitioned into SUVs of DPPC, displayed the same
pattern as previously described for t-PnA. In particular, the
abrupt variation undergone by the antibiotic mean lifetime
with the temperature (Fig. 10 c) reported accurately the
thermotropic transition temperature of DPPC obtained for
large unilamellar and multilamellar vesicles (T, = 41.4 ±
0.5°C; Marsh, 1990) and not the one expected for SUVs
(Tc- 380C; Harkness and White, 1979). This result pro-
vides then additional evidence for the fusion/aggregation of
the lipid vesicles induced by the binding of Nystatin. It
should also be noted that the longest-lived decay component
of Nystatin did not persist at temperatures above Tc, which
is at variance with what was observed with t-PnA.
An important finding of our study that to our knowledge
had not been described before for a tetraene fluorophore is
the concentration dependence shown by the emission decay
kinetics of Nystatin in gel-phase lipids. Although the anal-
ysis of the fluorescence decay of the antibiotic in this lipid
phase always required a long-lived component for the fit to
converge to a low x2 value, it had a very small amplitude
associated with it for Nystatin concentrations lower than
5-6 ,uM. Above this concentration, however, this normal-
ized pre-exponential acquired a significant value and
this increase could account almost by itself for the simul-
taneous change measured in the mean lifetime of the
antibiotic (Fig. 8).
The observation that this variation in the emission decay
kinetics of Nystatin took place upon increasing its concen-
tration in solution raised the possibility that it could be
associated with an extended perturbation of the bilayer
properties because of an increased partitioning of the anti-
biotic into the lipid vesicles. The association of a foreign
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molecule to a gel-like lipid bilayer is anticipated to occur in
a local defect, probably contributing to the disorganization
of the phospholipids surrounding the molecule. Therefore, if
this hypothesis were correct, a decrease in the normalized
amplitude of the long-lived decay component of Nystatin
upon increasing the overall antibiotic concentration in so-
lution would be expected, and not the opposite effect. An-
other possibility is that this photophysical behavior of Ny-
statin could be associated with the fusion/aggregation of the
vesicles. However, this hypothesis is contradicted by the
step-like dependence measured for the antibiotic mean life-
time with its concentration, because a monotonous increase
would then be predicted. Moreover, preliminary experi-
ments carried out with large unilamellar vesicles (Coutinho
and Prieto, manuscript in preparation), where the fusion/
aggregation of the vesicles induced by the antibiotic is not
significant, gave a similar dependence of the mean lifetime
on the antibiotic concentration in solution, although with a
smoother variation.
By combining the above considerations of the photophys-
ics of t-PnA with our present results, it can then be con-
cluded that Nystatin is sensing a more rigid environment,
i.e., it is experiencing a more restricted mobility, upon
increasing its total concentration. To explain this observa-
tion, it is necessary to assume that at least two antibiotic
species coexist in the bilayer. These could be distinct states
of aggregation of the antibiotic in the bilayer because the
self-association of Nystatin could decrease the nonradiative
rate constant of this molecule and, consequently, cause an
increase in its mean lifetime. In fact, it has been reported
that the sensitivity of t-PnA lifetime to the environment is
due primarily to variations in its nonradiative rate constant
(Sklar et al., 1977a). Therefore, by assuming that the radi-
ative rate constant and molar absorptivity of each antibiotic
species in the bilayer are the same and considering only a
two-states model for the sake of simplicity, the molar frac-
tion of antibiotic with the longest mean lifetime, XL, may be
estimated from its normalized fluorescence amplitude, i.e.,
XL = a3. This same procedure has been previously used to
compute the fraction of t-PnA in bilayer regions with dif-
ferent lateral densities (Mateo et al., 1991, 1993).
The concentration dependence of a3, and consequently of
XL, displayed in Fig. 8 a shows a cooperative character,
confirming that the antibiotic is self-associating. The soni-
cation experiment gives additional support to this conclu-
sion. Two possible explanations can then be put forward to
explain this result. First, different antibiotic species, e.g.,
monomers and aggregates pre-assembled in the aqueous
phase, could be partitioning between the aqueous and lipid
phases. On the other hand, Nystatin self-association could
be a process restricted to monomeric antibiotic molecules
already in interaction with the lipid bilayer. The first hy-
pothesis, however, does not seem plausible because 1) it
would require that the aggregates of antibiotic exhibited the
same molecular arrangements in very different environ-
ments. Yet, inverted molecular organizations, i.e., with the
toward the inside of the aggregate in the aqueous and lipid
phases, respectively, are a more likely picture. Also, 2) the
critical concentration measured for the aggregation process
in the membrane (-6 ,uM) does not coincide with the value
obtained in aqueous solution (3 ,LM). And finally, 3) the
dilution experiment with antibiotic-free lipid vesicles pro-
vided evidence for the rapid redistribution of antibiotic
molecules between the lipid vesicles, in agreement with was
previously shown to occur with AmpB (Bolard et al., 1981).
Furthermore, this experiment suggests that the main factor
controlling the formation of the long-lived Nystatin species
is the antibiotic-to-lipid ratio used. An important point that
should be stressed is that the aggregation model discussed
above does not exclude the possibility that simultaneously
with its self-association, Nystatin may be also undergoing a
change in its location in the lipid vesicles, e.g., moving from
the surface of the membrane to the interior of the bilayer.
This issue will be addressed in a later paper (Coutinho and
Prieto, manuscript in preparation).
The fluorescence decay parameters displayed by Nystatin
deserve a further comment. These values exhibit a close
similarity with those published for t-PnA (Mateo et al.,
1993), only for concentrations larger than -6 ,AM, when the
antibiotic is aggregated in the lipid bilayer. Below this
critical concentration, the mean lifetime measured for Ny-
statin is considerably shorter than the typical values mea-
sured for t-PnA in gel phase lipids. The distinct locations in
the lipid vesicles predicted for the fluorescent groups of
each molecule, and thereby the different environments
sensed by each one, are again the most likely justification
for their different photophysical properties. At low concen-
trations, Nystatin must be monomeric and presumably ad-
sorbed at the bilayer surface, whereas the fluorophore
of t-PnA is always deeply inserted in the lipid bilayer
(Castanho et al., 1995). This shallower location of Nystatin
must confer a less rigid environment with a higher polariz-
ability for its chromophore, and hence its long-lived fluo-
rescence decay component has a smaller associated ampli-
tude.
It is also interesting to note the absence of any spectral
alteration upon Nystatin aggregation in the lipid bilayer.
Because the most likely picture for the structure of a Ny-
statin aggregate is a stacked arrangement of antibiotic mol-
ecules with their transition dipoles parallel to each other,
one would anticipate the appearance of a new blueshifted
band in Nystatin absorption spectrum upon its self-associ-
ation in the bilayer due to exciton coupling between the
tetraene chromophores. In fact, the observation of this type
of interactions has previously been used to demonstrate the
close binding of the first two fluorescent fatty acids to
albumin (Berde et al., 1979) and the aggregation of t-Pna in
the lipid vesicles (Sklar et al., 1979). These spectral alter-
ations are also very characteristic of the polyene antibiotics
(Castanho et al., 1992; Balakrishnan and Easwaran, 1993a).
It should be noted, however, that the physical requirements
(distances and relative dipole orientations) for the exciton
antibiotic polar groups oriented toward the outside and
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coupling between two neighboring chromophores are very
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strict (Cantor and Schimmel, 1980). Therefore, the absence
of any spectral alteration in the excitation spectrum of
Nystatin at concentrations higher than 5-6 ,uM suggests
that its chromophores are not in sufficiently close contact
for an exciton interaction between their transition dipoles to
be possible.
For the lipid vesicles in liquid-crystalline phase, the de-
cay parameters of Nystatin were shown to be concentration
independent (Fig. 8 c), suggesting that the antibiotic is
monomeric within the concentration range studied. It is not
possible to discriminate between a lower partition coeffi-
cient of Nystatin and the different structural characteristics
displayed by the bilayer at this temperature as the main
reasons for this behavior of Nystatin. Ultimately, these
hypothesis are related, i.e., at this temperature the highly
disordered state of the acyl chains of the phospholipids
induced a decrease in the partition of the antibiotic between
the aqueous and lipid phases, and therefore reduced the
probability of self-association of the antibiotic in the lipid
bilayer.
Relation of results to AmpB
It has usually been assumed that the molecular basis of
Nystatin and AmpB action at the membrane level may be
described by a single common model, although Nystatin
displays an activity that is generally weaker than that of
AmpB (Bolard, 1986).
Because of their amphiphilic character, these molecules
readily aggregate in aqueous solution, rendering the char-
acterization of the first steps involved in their interaction
with the phospholipid bilayer membranes very difficult. CD
has been extensively used in the elucidation of this problem,
particularly for AmpB (Bolard et al., 1980; Vertut-Croquin
et al., 1983; Jullien et al., 1988; Balakrishnan and Easwaran,
1993a), because it was shown to be a very sensitive spec-
troscopy capable of monitoring different antibiotic forms in
the lipid bilayer. These studies demonstrated that the mea-
surement of a specific CD spectrum for AmpB was criti-
cally dependent on several factors such as the type of the
vesicle used, the physical state of the phospholipids, the an-
tibiotic-to-lipid ratio used (R), the sterol content of the
vesicles, and the time elapsed after sample preparation.
Most importantly, for SUVs prepared with saturated phos-
pholipids and without sterols, AmpB exhibited distinct CD
spectra at low and high molar ratios of antibiotic to total
lipid, which could also differ for the vesicles in gel or
liquid-crystalline phases (Bolard et al., 1981; Bolard
and Cheron, 1982; Jullien et al., 1988; Balakrishnan and
Easwaran, 1993a). These spectra were generally interpreted
as being due to monomeric antibiotic interacting with the
lipid bilayer (at low R) and to the formation of aggregates of
AmpB (at high R). Although a direct extrapolation of these
results to Nystatin cannot be made, these data nevertheless
support the conclusions of the present work.
CONCLUSIONS
Steady-state and time-resolved fluorescence measurements
were used in the present work to study Nystatin interaction
with a membrane model system composed of a single phos-
pholipid (DPPC); in addition, its behavior in methanol and
aqueous solution was characterized. This polyene macrolide
antibiotic is intrinsically fluorescent and its tetraene fluoro-
phore proved to be an excellent reporter of the structural
organization of the antibiotic, both in homogeneous media
and in lipid bilayers. In methanol, Nystatin was monomeric
until a concentration of 100-200 ,uM was reached, whereas
in aqueous solution the antibiotic was shown to aggregate
with a critical concentration of 3 t,M. Moreover, the steady-
state fluorescence anisotropy measurements showed that
Nystatin self-association in buffer followed a micellization-
type equilibrium, i.e., the antibiotic formed aggregates with
an approximately constant volume. The enhancement in the
fluorescence intensity of Nystatin was used to assess its
binding to the phospholipid vesicles and it was shown that
Nystatin partitioned preferentially into gel phase lipids in-
stead of fluid lipids, with an almost fivefold larger partition
coefficient. Furthermore, a time-resolved fluorescence
study was used to demonstrate Nystatin self-association in
gel-phase DPPC vesicles. The antibiotic intensity-weighted
mean lifetime, which was shown to be essentially controlled
by the amplitude of the longest-lived decay component,
displayed an abrupt transition in its value from 10 to 33 ns
at an overall antibiotic concentration in solution of 5-6 ,uM.
This observation was explained by a self-association of
monomeric antibiotic molecules within the lipid bilayer;
the fluorophore of Nystatin experienced a more rigid
environment in the aggregates and thus its mean lifetime
increased. It should be stressed that some experimental
results and the main conclusions of this work contradict
a previous fluorescence study of Nystatin performed by
Petersen et al. (1987). Specifically, in this work no flu-
orescence self-quenching was observed for Nystatin; this
antibiotic definitely self-associates in lipid vesicles, but
the new species formed were shown to be even more
fluorescent than the monomers. Moreover, the hypothesis
that energy migration (dipolar mechanism) could be op-
erative with Nystatin was completely ruled out, and ac-
cordingly, the steady-state fluorescence anisotropy mea-
sured for this antibiotic was shown to be independent of
the antibiotic concentration in the lipid vesicles.
APPENDIX
The binding experiments were analyzed assuming that Nystatin distributes
itself between the aqueous, Nw, and lipid, N,, phases according to a
partition equilibrium upon its interaction with phospholipid vesicles:
NWz± N, (I.1)
The partition coefficient, P, that governs this equilibrium is defined by
[N]1
=f] (1.2)
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where [N], = nl/vl and [N]1 = n/lv, are the concentrations of Nystatin in
lipid and aqueous phases, respectively; v1 and v, are the volumes of the
respective phases and n1 and n, denote the amount of Nystatin in each
phase. The overall concentration of Nystatin, [N]1, is given by
[N]t= [N]1 - + [N]]w V (1.3)Vt Vt
where vt is the total volume of the solution.
These experiments used the increase in the quantum yield, 4, of
Nystatin upon its interaction with the lipid vesicles to monitor the extent of
the antibiotic-phospholipid vesicle association. As long as the molar ab-
sorptivities of both Nystatin species at the excitation wavelength do not
differ much, Eq. I.4 holds for each antibiotic concentration studied:
I = XWIw + X1I1 (1.4)
In the above expression, xi and IA correspond to the mole fraction and the
fluorescence intensity of the antibiotic in state i, respectively, where i = w
represents the antibiotic present in the aqueous phase and i = 1 the
antibiotic partitioned into the membrane.
As with any other spectroscopic technique, this method relies on the
explicit assumption that the fractional partition of Nystatin into the phos-
pholipid vesicles is linearly proportional to the fractional change in its
quantum yield, which is directly reflected in its fluorescence intensity:
I-Iw
XI = W(.5)
Re-expressing Iw as Io, i.e., the fluorescence intensity of the antibiotic
measured in the absence of phospholipid vesicles and I, as I4, i.e., the
limiting value of I measured upon increasing the lipid concentration of the
solution, [L] = n1/vt and considering vt vw, Eq. I.5 can be rewritten as
AImax[L] U6
1/(Py) + [L]
where y is the molar volume of the lipid, Al = I - IO and Al,,. = I,. - Io.
Finally, for a given antibiotic concentration the previous equation can
be used to fit the experimental results (AI versus [L] data) by a nonlinear
least-squares regression method to provide estimates for the unknown
parameters, Almax and P.
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